Aurec Group

Aurec Group is a prominent Israeli holding company and private equity firm founded by Morris Kahn and Shmuel Meitar. While historically known for its foundational role in telecommunications (Amdocs) and media, the group has a significant and long-standing presence in the life sciences sector through its investment arms, Aurec Capital and Aurum Ventures. The group focuses on identifying and scaling high-impact healthcare and biotechnology innovations, with a portfolio that has included companies such as Vascular Biogenics, PolyPid, and Nucleix. Beyond direct investment, the group is heavily involved in medical research philanthropy, supporting institutions like the Weizmann Institute of Science and the Prostate Cancer Foundation.